According to BioIntel360, diabetes market in Spain is expected to grow by 9.3% on annual basis to reach US$1,335.8 million in 2025. The diabetes market in the country has experienced robust growth du...
According to BioIntel360, diabetes market in Spain is expected to grow by 9.3% on annual basis to reach US$1,335.8 million in 2025. The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 10.1%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.8% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 1,222.1 million to approximately USD 1,967.1 million. Key Trends and Drivers in Spain The Spanish diabetes devices and therapeutics market is evolving with increased CGM adoption, the integration of digital health platforms, advances in connected therapeutic delivery systems, and refined regulatory policies. These trends will intensify over the next 2–4 years, supporting more efficient patient monitoring and treatment management across Spain. Increase Adoption of Continuous Glucose Monitoring (CGM) • Spanish healthcare providers are integrating continuous glucose monitoring systems into diabetes management protocols across public hospitals and specialized clinics. Regional pilot projects in areas such as Madrid and Catalonia are incorporating CGM data to support individualized treatment planning. • Updated reimbursement policies from Spain’s National Health System (SNS) and revised clinical guidelines have contributed to wider CGM acceptance. Recent studies from Spanish research institutes underline the role of real-time data in improving glycemic control. • CGM adoption is projected to intensify as reimbursement pathways and clinical evidence expand. Enhanced patient monitoring is expected to support more timely treatment adjustments across Spain. Adopt Digital Health Solutions for Remote Monitoring • Digital platforms supporting remote monitoring and telemedicine are being implemented in diabetes care settings. Instances include initiatives in regions such as Andalusia and the Basque Country, where digital dashboards consolidate patient data. • Government-backed digital health strategies and recent policy updates have encouraged remote monitoring tools. Broader shifts in healthcare delivery models and increased MedTech investments further support integrating digital solutions in diabetes management. • The expansion of digital health solutions is expected to continue, improving connectivity between patients and healthcare providers. Over the medium term, this trend is likely to intensify, facilitating more efficient patient management and data-driven clinical decisions. Advanced Therapeutic Delivery Systems • Connected therapeutic devices, such as smart insulin pens and automated insulin pumps, are being introduced in the Spanish market. Clinical trials in selected Spanish hospitals have assessed these devices for improved dosing precision and treatment adherence. • Technological progress and supportive findings from recent local studies have driven the development of these delivery systems. Adjustments in reimbursement models and increased investment in MedTech innovations also contribute to their market entry. • The adoption of connected therapeutic devices is expected to grow steadily as clinical guidelines and reimbursement frameworks evolve. This trend may lead to more precise treatment regimens and improved overall diabetes management in Spain. Regulatory and Reimbursement Frameworks • Spanish regulatory bodies are updating approval processes and reimbursement frameworks to better accommodate new diabetes devices and therapies. Recent policy updates from health authorities such as the Ministry of Health highlight efforts to streamline device integration into clinical practice. • Broader healthcare reform initiatives and cost-containment measures are prompting these regulatory adjustments. Recent publications emphasize the need for clear reimbursement pathways to support digital and traditional diabetes care solutions. • A more defined regulatory framework will bolster market confidence and attract further investment in advanced diabetes technologies. Over the next few years, these adjustments are expected to intensify, paving the way for improved patient access and market growth. Competitive Landscape in Spain The Spanish market for diabetes devices and therapeutics features a dynamic mix of multinational leaders and emerging local innovators. Recent strategic partnerships, mergers, and acquisitions are reshaping the competitive landscape, with an increasing emphasis on digital integration and regulatory alignment. In the coming years, intensified competition and strategic consolidation are expected to drive innovation and enhance patient management across Spain. Analyze Current Market Conditions • The Spanish market comprises a mix of longstanding multinational companies and emerging local innovators. A structured National Health System provides defined reimbursement pathways that support device adoption and market entry. Key Players and New Entrants • Multinational manufacturers maintain a strong presence through long-term contracts with the Spanish health system and established distribution networks. These companies offer a broad portfolio, including monitoring devices and therapeutic systems. • Local startups and technology firms are entering the market with digital health solutions tailored to the Spanish context. Recent market analyses indicate that these entrants leverage pilot programs and regional collaborations to establish their presence. Review Recent Partnerships, Mergers, and Acquisitions • Recent publications detail partnerships between established firms and local digital health companies to improve device connectivity and data integration. Mergers and acquisitions reported in the past 12 months suggest efforts to consolidate expertise and expand product offerings within Spain. • These strategic activities contribute to a more interconnected market landscape, supporting shared innovation and efficient regulatory compliance. Consolidation efforts are aligning product development with the evolving needs of the Spanish healthcare system. Future Competitive Dynamics (Next 2–4 Years) • The competitive landscape is expected to evolve with further consolidation as large players expand their digital health capabilities and local entrants secure strategic alliances. Industry reports indicate emerging segmentation between providers of traditional devices and those focusing on digital health innovations. • Intensified competition will drive further innovation, resulting in refined product offerings and enhanced patient management strategies. Over the next 2–4 years, strategic collaborations and market consolidation are expected to shape Spain's competitive positioning. This report provides a detailed data-centric analysis of the diabetes industry in Spain, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics. BioIntel360’s research methodology is based on industry best practices. Its unbiased analysis leverages a proprietary analytics platform to offer a detailed view of emerging business and investment market opportunities.
This report provides an in-depth, data-centric analysis of the Spain diabetes devices and therapeutics market 2020-2029. Below is a summary of key market segments: Diabetes Devices and Therapeutics Market Share by Category • Diagnosis and Monitoring Devices • Therapeutics Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices • Blood Glucose Monitoring Devices • Insulin Delivery Devices • Diabetes Management and Mobile Applications • Artificial Pancreas Devices Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices • Self-Monitoring Blood Glucose Devices • Continuous Blood Glucose Monitoring Devices • Test Strips • Lancets Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices • Insulin Pumps • Insulin Pens • Insulin Syringes Diabetes Devices and Therapeutics Market Share by Therapeutics • Oral Anti-Diabetic Drugs • Insulin • Non-Insulin Injectable Drugs • Combination Drugs Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs • Alpha-Glucosidase Inhibitors • DPP-4 Inhibitors • SGLT-2 Inhibitors Diabetes Devices and Therapeutics Market Share by Insulin • Basal or Long-Acting • Bolus or Fast-Acting • Traditional Human Insulin Drugs • Insulin Biosimilars Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs • GLP-1 Receptor Agonists • Amylin Analogue Diabetes Devices and Therapeutics Market Share by Combination Drugs • Combination Insulin • Oral Combination Diabetes Devices and Therapeutics Market Share by Route of Administration • Subcutaneous • Intravenous • Others Diabetes Devices and Therapeutics Market Share by Type of Diabetes • Type 1 Diabetes • Type 2 Diabetes Diabetes Devices and Therapeutics Market Share by Distribution Channels • Online Pharmacies • Hospital Pharmacies • Retail Pharmacies Diabetes Devices and Therapeutics Market Share by End User • Hospitals • Diabetes Clinics • Homecare
• Comprehensive understanding of market structure and dynamics: Gain a detailed view of the diabetes devices and therapeutics market, including category-level segmentation (Diagnosis & Monitoring Devices and Therapeutics) and sub-segmentation by product type, route of administration, type of diabetes, distribution channel, and end user. • Identify high-growth segments and strategic investment areas: Use segment-wise market sizing and forecasting to identify opportunities in areas such as continuous glucose monitoring, insulin delivery technologies, oral anti-diabetic drugs, and biosimilars. Tailor your market entry or expansion strategies accordingly. • Benchmark performance across distribution and care settings: Access share analysis across online, hospital, and retail pharmacies, and evaluate usage patterns across hospitals, diabetes clinics, and homecare to support channel-specific planning and resource allocation.
1 Spain Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029 2 Spain Diabetes Devices and Therapeutics Market Share by Category, 2020-2029 2.1 Spain Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029 2.2 Spain Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029 3 Spain Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029 3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029 3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029 3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029 3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029 4 Spain Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029 4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029 4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029 4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029 4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029 5 Spain Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029 5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029 5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029 5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029 6 Spain Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029 6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029 6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029 6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029 6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029 7 Spain Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029 7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029 7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029 7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029 8 Spain Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029 8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029 8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029 8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029 8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029 9 Spain Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029 9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029 9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029 10 Spain Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029 10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029 10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029 11 Spain Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029 11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029 11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029 11.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029 12 Spain Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029 12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029 12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029 13 Spain Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029 13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029 13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029 13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029 14 Spain Diabetes Devices and Therapeutics Market Share by End User, 2020-2029 14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029 14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029 14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
Table 1: Spain Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029 Table 2: Spain Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029 Table 3: Spain Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029 Table 4: Spain Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Table 5: Spain Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029 Table 6: Spain Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029 Table 7: Spain Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029 Table 8: Spain Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029 Table 9: Spain Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Table 10: Spain Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029 Table 11: Spain Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029 Table 12: Spain Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029 Table 13: Spain Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029 Table 14: Spain Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029 Table 15: Spain Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029 Table 16: Spain Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029 Table 17: Spain Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029 Table 18: Spain Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029 Table 19: Spain Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029 Table 20: Spain Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029 Table 21: Spain Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029 Table 22: Spain Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029 Table 23: Spain Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029 Table 24: Spain Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029 Table 25: Spain Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029 Table 26: Spain Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029 Table 27: Spain Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029 Table 28: Spain Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029 Table 29: Spain Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029 Table 30: Spain Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029 Table 31: Spain Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029 Table 32: Spain Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029 Table 33: Spain Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029 Table 34: Spain Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029 Table 35: Spain Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029 Table 36: Spain Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029 Table 37: Spain Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029 Table 38: Spain Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029 Table 39: Spain Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029 Table 40: Spain Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
Figure 1: Spain Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029 Figure 2: Spain Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029 Figure 3: Spain Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029 Figure 4: Spain Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029 Figure 5: Spain Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029 Figure 6: Spain Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Figure 7: Spain Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029 Figure 8: Spain Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029 Figure 9: Spain Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029 Figure 10: Spain Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029 Figure 11: Spain Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029 Figure 12: Spain Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029 Figure 13: Spain Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029 Figure 14: Spain Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029 Figure 15: Spain Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029 Figure 16: Spain Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029 Figure 17: Spain Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029 Figure 18: Spain Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029 Figure 19: Spain Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029 Figure 20: Spain Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029 Figure 21: Spain Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029 Figure 22: Spain Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029 Figure 23: Spain Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029 Figure 24: Spain Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029 Figure 25: Spain Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029 Figure 26: Spain Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029 Figure 27: Spain Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029 Figure 28: Spain Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029 Figure 29: Spain Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029 Figure 30: Spain Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029 Figure 31: Spain Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029 Figure 32: Spain Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029 Figure 33: Spain Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029 Figure 34: Spain Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029 Figure 35: Spain Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029 Figure 36: Spain Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029 Figure 37: Spain Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029 Figure 38: Spain Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029 Figure 39: Spain Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029 Figure 40: Spain Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029 Figure 41: Spain Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029 Figure 42: Spain Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029 Figure 43: Spain Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029 Figure 44: Spain Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029 Figure 45: Spain Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029 Figure 46: Spain Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029 Figure 47: Spain Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029 Figure 48: Spain Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029 Figure 49: Spain Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029 Figure 50: Spain Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029 Figure 51: Spain Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029 Figure 52: Spain Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029 Figure 53: Spain Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
